Skip to main content
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
185.40
+3.39 (1.86%)
At close: Mar 9, 2026, 4:00 PM EDT
185.41
+0.01 (0.01%)
After-hours: Mar 9, 2026, 7:51 PM EDT

Jazz Pharmaceuticals Revenue

In the year 2025, Jazz Pharmaceuticals had annual revenue of $4.27B with 4.88% growth. Jazz Pharmaceuticals had revenue of $1.20B in the quarter ending December 31, 2025, with 10.09% growth.

Revenue (ttm)
$4.27B
Revenue Growth
+4.88%
P/S Ratio
2.67
Revenue / Employee
$1,476,673
Employees
2,890
Market Cap
11.41B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.27B198.64M4.88%
Dec 31, 20244.07B234.75M6.12%
Dec 31, 20233.83B174.83M4.78%
Dec 31, 20223.66B565.14M18.26%
Dec 31, 20213.09B730.67M30.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Bio-Techne 1.22B
Madrigal Pharmaceuticals 958.40M
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
BridgeBio Pharma 502.08M
ImmunityBio 113.29M
Revenue Rankings

JAZZ News

More News